A Google search resulted in this:
The third step in testing an experimental drug (or other treatment) in humans. Phase 3 trials are conducted to confirm and expand on safety and effectiveness results from Phase 1 and 2 trials, to compare the drug to standard therapies for the disease or condition being studied, and to evaluate the overall risks and benefits of the drug.
https://clinicaltrials.gov/ct2/show/NCT04292899
,,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)''
The title doesn't contain Efficacy :(
A better clinical trial (but with fewer participants) will be run in Norwegia, but we're supposed to get results only in August. I don't understand why we're losing so much time by not running studies all the time.
https://clinicaltrials.gov/ct2/show/NCT04321616?term=Remdesi...
"Because Indonesians come from Indonesia, and Russians come from Russia, Norwegians come from Norwegia." - Urban Dictionary
Also, they are competing with 265 other trials actively recruiting in the US.
In this research it looks to me like Gilead doesn't really want to show how (in)efficient remdesivir is in reality.
From 2400 participants there would have been enough for a control arm.
There's also a recently released monkey study showing huge improvements, so it's more likely than not remdesivir works (https://www.biorxiv.org/content/10.1101/2020.04.15.043166v1)
> Mullane, while encouraged by the University of Chicago data, made clear her own hesitancy about drawing too many conclusions. “It’s always hard,” she said, because the severe trial doesn’t include a placebo group for comparison.
Here is some historical perspective about using placebos while people are getting infected and dying:
* https://rootsofprogress.org/polio-and-the-controversy-over-r...
* https://rootsofprogress.org/more-on-polio-and-randomized-cli...